scholarly journals Relationship of High‐Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin

2018 ◽  
Vol 7 (2) ◽  
Author(s):  
Kwok Leung Ong ◽  
David D. Waters ◽  
Rana Fayyad ◽  
Liffert Vogt ◽  
Shari Melamed ◽  
...  
2011 ◽  
Vol 31 (2) ◽  
pp. 224-226
Author(s):  
Cheng-cheng YI ◽  
WEN-wen LIU ◽  
Ying-qiu ZHANG ◽  
Zhi-jun GUO ◽  
Xiang-yun WANG ◽  
...  

2020 ◽  
Author(s):  
Congcong Ding ◽  
Yang Chen ◽  
Yumeng Shi ◽  
Minghui Li ◽  
Lihua Hu ◽  
...  

Abstract Background: Data on the relationship of nontraditional lipid profiles [total cholesterol (TC)/high-density lipoprotein cholesterol (HDL-C) ratio, triglyceride (TG)/HDL-C ratio, low-density lipoprotein cholesterol (LDL-C)/HDL-C ratio, non-high-density lipoprotein cholesterol (non-HDL-C)] with the risk of peripheral artery disease (PAD) are limited. The present study investigated the relationship of nontraditional lipid indices with PAD in hypertensive patients.Methods: This cross-sectional study was performed among 10,900 adults with hypertension. Participants were diagnosed with PAD when their ankle-brachial index (ABI) < 0.9. The association of nontraditional lipid profiles with PAD was examined using multivariate logistic regression analysis and the restricted cubic spline.Results: All nontraditional lipid indices were independently and positively associated with PAD in a dose-response fashion. After multivariable adjustment, the per SD increments of the TC/HDL-C, TG/HDL-C, LDL-C/HDL-C ratios and non-HDL-C were all significantly associated with 37%, 14%, 40%, and 24% higher risk for PAD, respectively. The adjusted ORs (95% CI) for PAD were 1.77 (1.31, 2.40), 1.71 (1.25, 2.34), 2.03 (1.50, 2.74), and 1.70 (1.25, 2.31) when comparing the highest tertile to the lowest tertile of the TC/HDL-C, TG/HDL-C, LDL-C/HDL-C ratios and non-HDL-C, respectively. Conclusions: Among Chinese hypertensive adults, all nontraditional lipid indices were positively associated with PAD, and the LDL-C/HDL-C and TC/HDL-C ratios were better for predicting PAD than other nontraditional lipid indices, which may improve the risk stratification of cardiovascular disease and dyslipidemia management. Trial registration: CHiCTR, ChiCTR1800017274. Registered 20 July 2018


1986 ◽  
Vol 39 (9) ◽  
pp. 687-697 ◽  
Author(s):  
Jane A. Cauley ◽  
Ronald E. La Porte ◽  
Rivka Black Sandler ◽  
Trevor J. Orchard ◽  
Charles W. Slemenda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document